SubscribeHere’s a bold prediction for the new year. By 2020, the American health insurance industry will be extinct. Insurance companies will be replaced by ac-countable care organizations (ACOs) —groups of doctors, hospitals and other health care providers who come together [ Read More ]
Imagine that you are a patient who has been recently diagnosed with cancer. While you are still recovering from a difficult surgery to remove the tumor, your oncologist advises you it is time to begin chemotherapy. You are relieved to [ Read More ]
The purpose of this article is to outline the benefits that pharmacists can play in cancer care. Each discipline within the interdisciplinary cancer team has people trained in a specific area of expertise. With the amount of information, the number [ Read More ]
Unexpected and unwanted oversight is becoming a more frequent element of practice, making it imperative that you understand current investigation and audit initiatives, and how to prepare and protect your practice. Understanding the Office of Inspector General The US Department [ Read More ]
Although most physicians are aware that one of the greatest risks they face is becoming disabled and unable to perform the “material and substantial” duties of their medical specialty, most are unaware that myriad types of disability insurance policies exist [ Read More ]
On March 1, 2010, Consultants in Blood Disorders and Cancer (CBC), PSC, in Louisville, KY, sold all its assets to Baptist Medical Associates, a division of Baptist East Hospital, and the physicians became employees of the hospital. The events leading [ Read More ]
This final article in our disability insurance series provides tips on how to compare one company’s policy to another company’s policy when shopping for disability insurance coverage. This will help you ultimately choose the right policy to best meet your [ Read More ]
More than 25 years ago, Dr Fitzhugh Mullan described the seasons of survival in a narrative of his personal experience of being diagnosed and treated for cancer and facing the other side of the stethoscope in the New England Journal [ Read More ]
The result of the November 17, 2011, hyperpartisan Congress is policymaking stuck firmly in division and gridlock. Many healthcare issues remain in contention, including key components of the Patient Protection and Affordable Care Act (ACA). Whereas some legislators have tried [ Read More ]
For those asking whether managed care will still be around in 5 or 10 years, or whether certain treatments for stage IV cancer will be relevant at the end of that timeframe, uncertainty clouds any potential answer. In contrast, the [ Read More ]